| pubmed-article:14616446 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0019994 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0203668 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0243161 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0332305 | lld:lifeskim |
| pubmed-article:14616446 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:14616446 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:14616446 | pubmed:dateCreated | 2003-11-17 | lld:pubmed |
| pubmed-article:14616446 | pubmed:abstractText | To determine if it is possible to exclude staging bone scans in a greater proportion of patients if more consideration is given to T stage and Gleason score, as recent guidelines from the National Institute of Clinical Excellence state that routine staging bone scans for prostate cancer are unnecessary in patients with a prostate specific antigen level (PSA) of < 10 ng/mL and Gleason scores of < 8. | lld:pubmed |
| pubmed-article:14616446 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14616446 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14616446 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14616446 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14616446 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14616446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14616446 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14616446 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:14616446 | pubmed:issn | 1464-4096 | lld:pubmed |
| pubmed-article:14616446 | pubmed:author | pubmed-author:DearnaleyD... | lld:pubmed |
| pubmed-article:14616446 | pubmed:author | pubmed-author:FisherCC | lld:pubmed |
| pubmed-article:14616446 | pubmed:author | pubmed-author:NormanA RAR | lld:pubmed |
| pubmed-article:14616446 | pubmed:author | pubmed-author:CookG JGJ | lld:pubmed |
| pubmed-article:14616446 | pubmed:author | pubmed-author:O'SullivanJ... | lld:pubmed |
| pubmed-article:14616446 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14616446 | pubmed:volume | 92 | lld:pubmed |
| pubmed-article:14616446 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14616446 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14616446 | pubmed:pagination | 685-9 | lld:pubmed |
| pubmed-article:14616446 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:meshHeading | pubmed-meshheading:14616446... | lld:pubmed |
| pubmed-article:14616446 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14616446 | pubmed:articleTitle | Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. | lld:pubmed |
| pubmed-article:14616446 | pubmed:affiliation | Academic Unit of Radiotherapy and Clinical Oncology, Institute of Cancer Research/Royal Marsden Hospital, Sutton, Surrey, UK. drjoesullivan@ireland.com | lld:pubmed |
| pubmed-article:14616446 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14616446 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14616446 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14616446 | lld:pubmed |
